Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 11 - 14 symbols : Lnth save search
POINT Biopharma Reports Third Quarter 2022 Financial Results and Announces Strategic Collaboration and Exclusive License Agreements with Lantheus Holdings
Published: 2022-11-14 (Crawled : 12:20) - globenewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -11.71%
H: 2.53%
C: -29.12%
LNTH | News | $62.34 1.4% 1.38% 1.3M
|
Health Technology
|
| O: -0.41%
H: 3.77%
C: 1.8%
biopharma collaboration license financial results
Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003
Published: 2022-11-14 (Crawled : 12:00) - globenewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -11.71%
H: 2.53%
C: -29.12%
LNTH | News | $62.34 1.4% 1.38% 1.3M
|
Health Technology
|
| O: -0.41%
H: 3.77%
C: 1.8%
pnt2002 biopharma collaboration commercialization license
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.